BM212 – 10 mg

Brand:
Cayman
CAS:
146204-42-4
Storage:
-20
UN-No:
Non-Hazardous - /

BM212 is an antimycobacterial compound.{37196} It inhibits the growth of laboratory and clinical isolate M. tuberculosis strains (MICs = 0.7-1.5 μg/ml), including strains resistant to ethambutol (Item No. 23713), isoniazid (Item No. 20378), rifampicin (Item No. 14423), and rifabutin (Item No. 16468). BM212 also inhibits the growth of M. fortuitum, M. smegmatis, M. kansasii, and M. avium strains (MICs = 3.1-12.5, 3.1-25, 3.1-6.2, and 0.4-3.1 μg/ml, respectively). It inhibits replication of intracellular M. tuberculosis in infected U937 macrophages in a dose-dependent manner at concentrations ranging from 0.5-10 μg/ml. Some M. smegmatis, M. bovis BCG, and M. tuberculosis H37Rv mutant strains carry mutations in the mycobacterium membrane protein large 3 (mmpL3) gene and are resistant to BM212, indicating mmpL3 is likely a cellular target of BM212.{37197}  

 

Available on backorder

SKU: 22986 - 10 mg Category:

Description

An antimycobacterial compound; inhibits the growth of laboratory and clinical isolate M. tuberculosis strains (MICs = 0.7-1.5 μg/ml); inhibits the growth of M. fortuitum, M. smegmatis, M. kansasii, and M. avium (MICs = 3.1-12.5, 3.1-25, 3.1-6.2, and 0.4-3.1 μg/ml, respectively); inhibits replication of intracellular M. tuberculosis in infected U937 macrophages in a dose-dependent manner at concentrations from 0.5-10 μg/ml


Formal name: 1-[[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl]-4-methyl-piperazine

Synonyms: 

Molecular weight: 414.4

CAS: 146204-42-4

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Antibiotics||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases|Tuberculosis